Post job

SciClone Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Brian J. Underdown Ph.D. is the SciClone Pharmaceuticals's CEO. SciClone Pharmaceuticals has 570 employees, of which 6 are in a leadership position.
Work at SciClone Pharmaceuticals?
Share your experience

Rate SciClone Pharmaceuticals' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Brian J. Underdown Ph.D.

Chief Executive Officer

Brian J. Underdown, PhD is a Chief Executive Officer at SCICLONE PHARMACEUTICALS INC.

Hong Zhao

Board Member

Hong Zhao is an Exec VP:Sales & Marketing at SIMCERE PHARMACEUTICAL GROUP, Board Member at SCICLONE PHARMACEUTICALS INC, and Visiting Professor at Nanjing Medical University. She has worked as CEO:China Operations at SCICLONE PHARMACEUTICALS INC, Executive Vice President at SIMCERE PHARMACEUTICAL GROUP, and Senior VP:Greater China/VP at Novartis Pharma Beijing. Hong works or has worked at Xian Janssen Pharma Ltd and works or has worked as General Manager at Novartis Nutrition Shanghai. She studied at China Europe International Business School - CEIBS and Nanjing Medical University.

Jon Saxe

Board Member

Marc Steuer

VP:Finance/CFO

Marc Steuer is a VP:Bus Development at PHARMACYCLICS INC, Board Member at EORM, and VP:Finance/CFO at SCICLONE PHARMACEUTICALS INC. He has worked as Exec Vice President at SCICLONE PHARMACEUTICALS INC, Senior VP:Business Development at PHARMACYCLICS INC, and Senior VP:Business Development at Telik Inc. Marc works or has worked as Various Positions at Pilkington PLC and Various Positions at Syntex Corp. He attended New York University and Columbia College, Columbia University.

Ting Ping

Board Member

Xiaoning Guo Ph.d

VP, Head of R&D and Chief Medical Officer

Xiaoning Guo Ph.d's LinkedIn

• 18+ year’s research experiences in drug discovery, translational medicine and clinical development in pharmaceuticals industry.• 12+ years' project and portfolio management experiences in big Pharm R&D organization.• Proven ability in leading multi-disciplinary teams and R&D projects from discovery to clinical development for both small molecules and biologics. • Expertise in biology and pharmacology in oncology and virology with extensive knowledge in Asia diseases • Strong experience in people development and project management including budget, timeline and resources.• Collaboration with internal and external partners globallySpecialties: - Pharmaceutical / Biotech industry / CRO in China - Strategic planning and budget, timeline and resources management - Project and portfolio management - Drug discovery & Clinical development

Do you work at SciClone Pharmaceuticals?

Does the leadership team provide a clear direction for SciClone Pharmaceuticals?

SciClone Pharmaceuticals jobs

SciClone Pharmaceuticals board members

Name & TitleBio
Hong Zhao

Board Member

Hong Zhao is an Exec VP:Sales & Marketing at SIMCERE PHARMACEUTICAL GROUP, Board Member at SCICLONE PHARMACEUTICALS INC, and Visiting Professor at Nanjing Medical University. She has worked as CEO:China Operations at SCICLONE PHARMACEUTICALS INC, Executive Vice President at SIMCERE PHARMACEUTICAL GROUP, and Senior VP:Greater China/VP at Novartis Pharma Beijing. Hong works or has worked at Xian Janssen Pharma Ltd and works or has worked as General Manager at Novartis Nutrition Shanghai. She studied at China Europe International Business School - CEIBS and Nanjing Medical University.

Jon Saxe

Board Member

Ting Ping

Board Member

SciClone Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of SciClone Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SciClone Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at SciClone Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SciClone Pharmaceuticals. The data presented on this page does not represent the view of SciClone Pharmaceuticals and its employees or that of Zippia.

SciClone Pharmaceuticals may also be known as or be related to SCICLONE PHARMACEUTICALS INC, SciClone Pharmaceuticals, SciClone Pharmaceuticals Holdings Co Ltd, SciClone Pharmaceuticals Inc, SciClone Pharmaceuticals Inc., SciClone Pharmaceuticals, Inc. and Sciclone Pharmaceuticals, Inc.